The news: 73% of US adults are behind on one or more routine cancer screenings, up 4% year over year, according to the Prevent Cancer Foundation’s 2026 Early Detection Survey.
Among those who missed screenings:
Why it matters: Cost is emerging as a key barrier to cancer screenings, even though preventative care is typically low cost or free for most consumers.
Implications for healthcare providers and marketers: Consistently missing preventive care increases the likelihood of later diagnoses and higher downstream costs.
While awareness campaigns—including two Super Bowl ads this year highlighting prostate and breast cancer screening—promote preventative care, they often fall short on what consumers need to act.
Healthcare and pharma marketers need to shift from broad messaging to practical support and next steps: what to do, when to do it, and what it will cost, if anything. That means replacing “talk to your doctor” messages with concrete tools like eligibility checklists, coverage explanations, and personalized reminders that include cost context.
This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.
You've read 0 of 2 free articles this month.
685 Third Avenue21st FloorNew York, NY 100171-800-405-0844
1-800-405-0844[email protected]